Status:
COMPLETED
Pharmacokinetic of Sevoflurane During a 48h Sedation in Intensive Care Unit With AnaConDa®
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
University Hospital, Estaing
Conditions:
Sedation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective clinical monocentric study in ICU with sedated ventilated patients with sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model of sevoflurane.
Detailed Description
Prospective clinical monocentric study in ICU with sedated ventilated patients with sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model of sévoflurane and its metabol...
Eligibility Criteria
Inclusion
- Adult patients ventilated more than 48 h
- Stable respiratory and hemodynamic conditions
- Consent of patients or family
- Arterial line
Exclusion
- Acute kidney injury
- Obesity
- Sevoflurane anaphylaxia
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01196754
Start Date
March 1 2008
End Date
May 1 2009
Last Update
September 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003